HCC: role of pre- and post-treatment tumor biology in driving adverse outcomes and rare responses to therapy.
HCC: role of pre- and post-treatment tumor biology in driving adverse outcomes and rare responses to therapy. Abdom Radiol (NY). 2021 08; 46(8):3686-3697.